Skip to main content
Premium Trial:

Request an Annual Quote

Abgenix, Agilent in Microarray Deal

NEW YORK, July 8-Abgenix will use Agilent's custom microarray platform, Agilent said today.

 

Abgenix researchers will have access to Agilent's microarray design services, custom oligo microarrays, microarray scanner, and the Rosetta software analysis system.

 

The companies did not disclose the financial specifics of the deal.

 

Abgenix focuses on developing and commercializing human antibodies for therapeutic use.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.